{"nct_id":"NCT02628067","title":"Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2015-12-18","start_date_type":"ACTUAL","primary_completion_date":"2027-05-04","primary_completion_date_type":"ESTIMATED","completion_date":"2027-05-04","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}